Becoming a Company Chosen by Investors
First written in FY2016. 8 of 9 entries say "Restated". Latest entry: FY2024.
72 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「① Strengthening initiatives to become a company chosen by investors ② Strengthening earnings generation through business development centered on the pharmacy business ③ Further strengthening the management foundation」
The company continues to pursue the 3 themes of LSG2024: investor value, earnings generation centered on the pharmacy business and strengthening the management foundation. - FY2023RestatedAnnual report
「On 24 December 2021, the group announced its medium-term management plan LSG (Leading to Sustainable Growth) 2024. To further enhance shareholder value, strengthen competitiveness and achieve growth, it is promoting ① stronger initiatives to become a company chosen by investors, ② stronger earnings generation through business development centered on the pharmacy business, and ③ improvements to its earnings structure through further strengthening of its management foundation.」
The company continues to focus on investor value, earnings generation centered on the pharmacy business and strengthening its management foundation as the key areas of LSG2024. - FY2023-Q1RestatedAnnual report
「On 24 December 2021, the group announced its medium-term management plan LSG (Leading to Sustainable Growth) 2024. To further enhance shareholder value, strengthen competitiveness and achieve growth, it is promoting ① stronger initiatives to become a company chosen by investors, ② stronger earnings generation through business development centered on the pharmacy business, and ③ improvements to its earnings structure through further strengthening of its management foundation.」
Under LSG2024 as well, the company continues to position “strengthening initiatives to become a company chosen by investors” as the plan's first priority. - FY2022RestatedAnnual report
「① Strengthening initiatives to become a company chosen by investors」
Under LSG2024 as well, the company continues to position its policy of becoming a company chosen by investors as the plan's first priority. - FY2022-Q2RestatedAnnual report
「① Strengthening initiatives to become a company chosen by investors」
Under the new medium-term management plan LSG2024, the company continues to position its policy of becoming a company chosen by investors as the plan's first priority. - FY2021RestatedAnnual report
「Under this medium-term management plan, the company is working to build a management foundation for continued strong growth while securing an appropriate level of earnings despite the expected severe changes in the business environment,」
The company continues its policy of building a growth platform through pharmacies, merchandise and reviews of its operating methods and organizational structure. - FY2020RestatedAnnual report
「Under this medium-term management plan, the company is pursuing initiatives to strengthen competitiveness in its pharmacy business and accelerate new store openings and M&A, expand and improve the profitability of its merchandise business, and improve its earnings structure by reviewing its operating methods and group organizational structure, in order to build a management foundation for continued strong growth while securing an appropriate level of earnings despite the expected severe changes in the business environment.」
The company continues its policy of building a growth platform through the 3 areas of pharmacies, merchandise and operating methods and organizational structure. - FY2018RestatedAnnual report
「The direction of this management strategy is not expected to change significantly, and the company is currently preparing its next medium-term management plan.」
The company is maintaining the direction of its medium-term management plan, which aims to become a company chosen by patients, users and investors. - FY2016First statedAnnual report
「The third initiative is to become a company chosen by investors, primarily by ① pursuing steady growth through continued store openings and M&A and ② accelerating measures to improve management efficiency, including subsidiary reorganization.」
The third theme of the medium-term management plan is to use store openings, M&A and subsidiary reorganization to become a company chosen by investors.